Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00874653|
Recruitment Status : Completed
First Posted : April 2, 2009
Last Update Posted : June 23, 2014
The purposes of this study are:
- To evaluate patient satisfaction for efficacy and tolerability of heavy menstrual bleeding treatment by Mirena.
- To collect italian data for Mirena in clinical routine.
|Condition or disease||Intervention/treatment|
|Menorrhagia||Drug: Levonorgestrel (Mirena, BAY86-5028)|
|Study Type :||Observational|
|Actual Enrollment :||78 participants|
|Official Title:||Levonorgestrel Releasing Intrauterine System (MIRENA) in Idiopathic Menorrhagia|
|Study Start Date :||April 2008|
|Actual Study Completion Date :||December 2008|
Drug: Levonorgestrel (Mirena, BAY86-5028)
Women using Mirena for intrauterine treatment of menorrhagia
- The quality of life on the basis of the validated Health-Related Quality of Life questionnaire (HRQL SF-36) [ Time Frame: at 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00874653
|Many Locations, Italy|
|Study Director:||Bayer Study Director||Bayer|